Science reports that Ohio State University cancer researcher Ching-Shih Chen resigned due to misconduct findings.
Prospective panel sequencing on colorectal cancer patients picked up Lynch syndrome with sensitivity and specificity that met or exceeded gene-by-gene tests.
The researchers plan to add the MSI detection capabilities to an NGS panel and will use the information to guide cancer patients to precision medicine trials.
Ohio State's Carlo Croce sues the New York Times over its article on research misconduct allegations, Retraction Watch reports.
In Science this week: genomic investigation of maize's adaption to temperate climates, and more.
Retraction Watch reports that PNAS has issued expressions of concern about two papers from Ohio State's Carlo Croce.
Ohio State University's Carlo Croce is facing new allegations of research misconduct, according to the New York Times.
The lead investigators said that Foundation Medicine's NGS test will enable the beginning of targeted treatment within seven days of diagnosis.
HudsonAlpha researchers are expected to sequence 20,000 patient tumor and non-tumor samples for ORIEN's Avatar initiative by 2019.
Ohio State's Steve Rissing writes that gene drives may be helpful, but also may be harmful.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.